Stocktoria

SUPERNUS PHARMACEUTICALS, INC. SUPN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2010-12-28 · LEI

SUPERNUS PHARMACEUTICALS, INC. statistics & valuation

Market cap$2.7B
P / S3.8×
P / B2.6×
P / FCF59.1×
Net margin-5.4%
Return on equity-3.6%
FCF margin6.4%
Return on capital-5.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
42.40% 19.00% 27.10% 28.80% 24.40% 9.20% 9.10% 0.20% 11.20% -5.40% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
25.20% 32.90% 35.30% 37.80% 33.40% 14.80% 6.90% -0.90% 12.30% -8.70% 2016201720182019202020212022202320242025
Return on equity (%)
47.60% 21.40% 24.50% 19.00% 17.00% 6.50% 6.90% 0.10% 7.10% -3.60% 2016201720182019202020212022202320242025
Shares outstanding
51.7M 53.3M 54.1M 53.8M 53.7M 54.4M 61.7M 55.5M 56.0M 57.5M 2016201720182019202020212022202320242025
Net debt ($)
$175.8M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
29.50% 13.50% 11.40% 9.70% 8.40% 3.20% 3.60% 0.10% 5.40% -2.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
30.30% 37.30% 31.30% 35.70% 25.90% 17.40% 18.20% 25.90% 6.40% 2016201720182019202020212022202320242025
Debt / equity (×)
0.46× 2016201720182019202020212022202320242025
EPS ($)
$1.76 $1.08 $2.05 $2.10 $2.36 $0.98 $1.04 $0.02 $1.32 -$0.68 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

SUPERNUS PHARMACEUTICALS, INC. trades at about 36.3× earnings — above its 10-year norm (10-year range 10.9×–1384×, median 31.5×).

10.9× 1384×

Shaded band = 10-year range (10.9×–1384×); dot = today's 36.3×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-8.7%12.3%-0.9%6.9%14.8%33.4%37.8%35.3%32.9%25.2%
Net margin-5.4%11.2%0.2%9.1%9.2%24.4%28.8%27.1%19.0%42.4%
FCF margin6.4%25.9%18.2%17.4%—25.9%35.7%31.3%37.3%30.3%
Return on assets-2.7%5.4%0.1%3.6%3.2%8.4%9.7%11.4%13.5%29.5%
Return on equity-3.6%7.1%0.1%6.9%6.5%17.0%19.0%24.5%21.4%47.6%
Debt / equity————0.46×—————
Current ratio1.902.351.701.071.912.572.943.061.861.88

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.